NewsBenzingaCDT Equity Partners With QIMA Life Sciences To Develop Several Of The Company's Autoimmune Skin Disease Assets, Including Novel Tapinarof Combinations In Psoriasis And Vitiligo CDT Equity Partners With QIMA Life Sciences To Develop Several Of The Company's Autoimmune Skin Disease Assets, Including Novel Tapinarof Combinations In Psoriasis And Vitiligo Benzinga 2026.09.18 10:33 (GMT+0) Open on Benzinga Other news Goldman Sachs Maintains Neutral on Moderna, Raises Price Target to $137 Goldman Sachs Maintains Buy on Delek US Holdings, Raises Price Target to $97 US memory chip stocks fall in pre-market trading, SK Hynix down nearly 8% Goldman Sachs Downgrades Par Pacific Hldgs to Neutral, Raises Price Target to $94 Zelenskyy Ends Ukraine’s Pause on Russian Oil Refinery Strikes After Trump-Backed Truce, Demands Patriot Missiles for Another Ceasefire: Report FDA Accepts Aquestive Therapeutics’ Anaphylm NDA Resubmission; PDUFA Goal Action Date Set For March 16, 2027
Zelenskyy Ends Ukraine’s Pause on Russian Oil Refinery Strikes After Trump-Backed Truce, Demands Patriot Missiles for Another Ceasefire: Report
FDA Accepts Aquestive Therapeutics’ Anaphylm NDA Resubmission; PDUFA Goal Action Date Set For March 16, 2027
